Key result
Fatty fish intake significantly reduces atherogenic ceramides and diacylglycerols in patients with coronary heart disease.
Why the study?
The physiological mechanisms behind the beneficial health effects of fish consumption are not completely known, and little information is available on how different types of fish affect serum lipidomic profiles in subjects with coronary heart disease.
Does a fatty fish or lean fish diet improve serum lipidomic profiles compared to a lean meat control diet in subjects with coronary heart disease?
RCT (n=33)
Parallel
Does a fatty fish or lean fish diet improve serum lipidomic profiles compared to a lean meat control diet in subjects with coronary heart disease?
Answers are grounded in this paper and cite their sources.
An 8-week diet of fatty fish (4 meals/week) significantly reduces bioactive lipids associated with inflammation and insulin resistance in patients with coronary heart disease, suggesting a potential mechanism for its cardiovascular protective effects.
Background The evidence of the multiple beneficial health effects of fish consumption is strong, but physiological mechanisms behind these effects are not completely known. Little information is available on the effects of consumption of different type of fish. The aim of this study was to investigate how fatty fish or lean fish in a diet affect serum lipidomic profiles in subjects with coronary heart disease. Methodology and Principal Findings A pilot study was designed which included altogether 33 subjects with myocardial infarction or unstable ischemic attack in an 8-week parallel controlled intervention. The subjects were randomized to either fatty fish (n = 11), lean fish (n = 12) or control (n = 10) groups. Subjects in the fish groups had 4 fish meals per week and subjects in the control group consumed lean beef, pork and chicken. A fish meal was allowed once a week maximum. Lipidomics analyses were performed using ultra performance liquid chromatography coupled to electrospray ionization mass spectrometry and gas chromatography. Multiple bioactive lipid species, including ceramides, lysophosphatidylcholines and diacylglycerols, decreased significantly in the fatty fish group, whereas in the lean fish group cholesterol esters and specific long-chain triacylglycerols increased significantly (False Discovery Rate q-value <0.05). Conclusions/Significance The 8-week consumption of fatty fish decreased lipids which are potential mediators of lipid-induced insulin resistance and inflammation, and may be related to the protective effects of fatty fish on the progression of atherosclerotic vascular diseases or insulin resistance. Trial Registration ClinicalTrials.gov NCT00720655
No takes yet. Share an insight, caveat, or question.
Lankinen et al. (2009) conducted an RCT in Coronary heart disease (myocardial infarction or unstable ischemic attack) (n=33). Fatty fish or lean fish diet vs. Control diet (lean beef, pork, and chicken; maximum 1 fish meal per week) was evaluated on Serum lipidomic profiles (bioactive lipid species including ceramides, lysophosphatidylcholines, diacylglycerols, cholesterol esters, and long-chain triacylglycerols) (p=<0.05 (FDR q-value)). Fatty fish intake (4 meals/week for 8 weeks) decreased ceramides, lysophosphatidylcholines, and diacylglycerols in CHD patients.
Synapse has enriched 10 related papers. Consider them for comparative context: